ABSTRACT
BACKGROUND: Bovine mastitis is characterized by an inflammatory process in the mammary gland and represents one of the main diseases affecting a dairy herd. Management of mastitis is most commonly via antibiotics, but the rising incidence of multiple antibiotic resistance (MAR) means that additional options are needed. Homeopathic products can be administered in dairy farming for a range of clinical reasons and may be preferential due to the absence of residues. OBJECTIVES: The aim of this study was to assess the potential of a novel homeopathic complex medicine in managing bovine mastitis. METHODS: Twenty-four lactating Holstein cows with mastitis were divided into two groups: the homeopathic complex group received a homeopathic complex daily for 60 days at a dose of 20 g/d; the placebo group received the calcium carbonate vehicle without homeopathic medicines at the same dose and repetition. The main outcome measure was somatic cell count (SCC; cells/mL), with additional outcome measures including milk production (kg/d), milk constituents (percentage of protein, fat, lactose and total milk solids), and serum levels of cortisol, glucose, ammonia and lactic acid. All outcomes were measured at the beginning of the study and after 30 and 60 days. Milk samples were also collected from all animals at the beginning of the study, confirming a high (>0.2) MAR index for isolated bacterial cultures. RESULTS: Assessment of SCC showed a statistically significant difference favoring the homeopathic complex versus placebo group at day 60. A reduction in serum cortisol levels and an increase in fat, lactose and total milk solids in animals treated with the homeopathic complex at day 60 were also seen. Other outcome measures did not show statistically significant inter-group differences. CONCLUSION: The results of this non-randomized, open-label, placebo-controlled trial suggest the potential for a novel homeopathic complex medicine in management of multiple antibiotic-resistant bovine mastitis, thus offering dairy farmers an additional option to antibiotics and making dairy products safer for consumer health and milk production more sustainable.
Subject(s)
Homeopathy , Mastitis, Bovine , Materia Medica , Animals , Cattle , Female , Anti-Bacterial Agents/pharmacology , Hydrocortisone , Lactation , Lactose , Mastitis, Bovine/drug therapy , Mastitis, Bovine/epidemiology , Mastitis, Bovine/microbiology , Materia Medica/pharmacologyABSTRACT
The present study examines the efficacy of a homeopathic dry cow prophylaxis in a randomized, placebo controlled case-control field trial. The study was conducted in 24 Brown Swiss farms in the Engadine (Swiss mountain region). The effect of the used homeopathic substances were combined with antibiotics in justified cases. At drying off and in the 3rd and 5th week of lactation the udders were clinically examined and quarter milk samples were taken for bacteriological and cytological analysis. In addition, milk recording data of the first 6 milk testing were included in the evaluations. The used homeopathic prophylaxis at drying off did not show any effect in the incidence of dry cow mastitis and mastitis in the first 120 days of lactation. However, at day 21 post partum significantly fewer animals in the verum group showed a bacteriological finding of a major pathogen, but more animals in this group suffered from a secretion disorder. It has been shown that at the 6th milk test pp significantly more animals of the verum group had a somatic cell count below 100'000 cells/ml than the control group.
Dans cette étude, on contrôle l'efficacité d'une prévention homéopathique lors du tarissement dans le cadre d'une étude randomisée versus placebo. L'étude a été réalisée dans 24 exploitations en Engadine, élevant de la race brune. L'efficacité des produits homéopathiques utilisés a également été considérée en tenant compte des antibiotiques appliquées dans les cas fondés. Chez tous les animaux on a recueilli un échantillon de chaque quartier lors du tarissement ainsi qu'en 3ème et 5ème semaine de lactation. Ces échantillons ont été examinés du point de vu bactériologique et quant au nombre de cellules. En outre, le taux de cellules des 6 premiers contrôles laitier a été intégré dans le calcul des résultats. La prévention homéopathique lors des tarissement n'a pas montré d'effet quant à l'apparition de mammites durant la période de tarissement ou durant les 120 premiers jours de la lactation. On a toutefois pu montrer que, 21 jours postpartum, le nombre d'animaux présentant des résultats bactériologiques avec des germes importants pour les mammites était significativement plus bas mais qu'un plus grand nombres d'animaux souffraient des troubles de la sécrétion. Lors du 6ème contrôle laitier postpartum, il y avait dans le groupe test plus d'animaux avec un taux de cellule inférieur à 100'000/ml que dans le groupe de contrôle.
Subject(s)
Mastitis, Bovine/prevention & control , Materia Medica/therapeutic use , Animals , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/therapeutic use , Cattle , Cell Count/veterinary , Female , Incidence , Lactation , Mammary Glands, Animal/microbiology , Mammary Glands, Animal/pathology , Mastitis, Bovine/epidemiology , Materia Medica/administration & dosage , Milk/cytology , Milk/microbiology , Postpartum Period , Switzerland/epidemiologyABSTRACT
AIM: To compare clinical and bacteriological cure rates of clinical mastitis following treatment with either antimicrobials or homeopathic preparations. METHODS: Seven spring-calving herds from the Waikato region of New Zealand were used to source cases of clinical mastitis (n = 263 glands) during the first 90â days following calving. Duplicate milk samples were collected for bacteriology from each clinically infected gland at diagnosis and 25 (SD 5.3) days after initial treatment. Affected glands were treated with either an antimicrobial formulation or a homeopathic remedy. Generalised linear models with binomial error distribution and logit link were used to analyse the proportion of cows that were clinical treatment cures and the proportion of glands that were classified as bacteriological cures, based on initial and post-treatment milk samples. RESULTS: Mean cumulative incidence of clinical mastitis was 7% (range 2-13% across herds) of cows. Streptococcus uberis was the most common pathogen isolated from culture-positive samples from affected glands (140/209; 67%). The clinical cure rate was higher for cows treated with antimicrobials (107/113; 95%) than for cows treated with homeopathic remedies (72/114; 63%) (p < 0.001) based on the observance of clinical signs following initial treatment. Across all pathogen types bacteriological cure rate at gland level was higher for those cows treated with antimicrobials (75/102; 74%) than for those treated with a homeopathic preparation (39/107; 36%) (p < 0.001). CONCLUSIONS AND CLINICAL RELEVANCE: Using herds located in the Waikato region of New Zealand, homeopathic remedies had significantly lower clinical and bacteriological cure rates compared with antimicrobials when used to treat post-calving clinical mastitis where S. uberis was the most common pathogen. The proportion of cows that needed retreatment was significantly higher for the homeopathic treated cows. This, combined with lower bacteriological cure rates, has implications for duration of infection, individual cow somatic cell count, costs associated with treatment and animal welfare.
Subject(s)
Anti-Bacterial Agents/therapeutic use , Bacterial Infections/veterinary , Dairying , Mastitis, Bovine/drug therapy , Materia Medica/therapeutic use , Postpartum Period , Animals , Bacterial Infections/drug therapy , Cattle , Female , Mastitis, Bovine/epidemiology , New Zealand/epidemiology , Plants, Medicinal , PregnancyABSTRACT
A dataset of test-day records, fertility traits, and one health trait including 1275 Brown Swiss cows kept in 46 small-scale organic farms was used to infer relationships among these traits based on recursive Gaussian-threshold models. Test-day records included milk yield (MY), protein percentage (PROT-%), fat percentage (FAT-%), somatic cell score (SCS), the ratio of FAT-% to PROT-% (FPR), lactose percentage (LAC-%), and milk urea nitrogen (MUN). Female fertility traits were defined as the interval from calving to first insemination (CTFS) and success of a first insemination (SFI), and the health trait was clinical mastitis (CM). First, a tri-trait model was used which postulated the recursive effect of a test-day observation in the early period of lactation on liability to CM (LCM), and further the recursive effect of LCM on the following test-day observation. For CM and female fertility traits, a bi-trait recursive Gaussian-threshold model was employed to estimate the effects from CM to CTFS and from CM on SFI. The recursive effects from CTFS and SFI onto CM were not relevant, because CM was recorded prior to the measurements for CTFS and SFI. Results show that the posterior heritability for LCM was 0.05, and for all other traits, heritability estimates were in reasonable ranges, each with a small posterior SD. Lowest heritability estimates were obtained for female reproduction traits, i.e. h(2)=0.02 for SFI, and h(2)≈0 for CTFS. Posterior estimates of genetic correlations between LCM and production traits (MY and MUN), and between LCM and somatic cell score (SCS), were large and positive (0.56-0.68). Results confirm the genetic antagonism between MY and LCM, and the suitability of SCS as an indicator trait for CM. Structural equation coefficients describe the impact of one trait on a second trait on the phenotypic pathway. Higher values for FAT-% and FPR were associated with a higher LCM. The rate of change in FAT-% and in FPR in the ongoing lactation with respect to the previous LCM was close to zero. Estimated recursive effects between SCS and CM were positive, implying strong phenotypic impacts between both traits. Structural equation coefficients explained a detrimental impact of CM on female fertility traits CTFS and SFI. The cow-specific CM treatment had no significant impact on performance traits in the ongoing lactation. For most treatments, beta-lactam-antibiotics were used, but test-day SCS and production traits after the beta-lactam-treatment were comparable to those after other antibiotic as well as homeopathic treatments.
Subject(s)
Anti-Bacterial Agents/therapeutic use , Cattle/physiology , Fertility , Mastitis, Bovine/genetics , Milk/metabolism , Animals , Cattle/genetics , Cattle/growth & development , Female , Lactation , Mastitis, Bovine/drug therapy , Mastitis, Bovine/epidemiology , Models, Genetic , Normal Distribution , Phenotype , Quantitative Trait, Heritable , Risk Factors , Switzerland/epidemiologyABSTRACT
BACKGROUND: Mastitis is one of the major threats to animal health, in organic farming as well as conventional. Preliminary studies of organic dairy herds have indicated better udder health in such herds, as compared to conventional herds. The aim of this paper was to further study mastitis and management related factors in certified organic dairy herds. METHODS: An observational study of 26 certified organic dairy herds in mid-eastern Sweden was conducted during one year. A large-animal practitioner visited the herds three times and clinically examined and sampled cows, and collected information about general health and management routines. Data on milk production and disorders treated by a veterinarian in the 26 herds, as well as in 1102 conventional herds, were retrieved from official records. Multivariable logistic regression was used to assess associations between herd type (organic vs. conventional) and incidence of disorders. RESULTS: The organic herds that took part in the study ranged in size from 12 to 64 cows, in milk production from 3772 to 10,334 kg per cow and year, and in bulk milk somatic cell counts from 83,000 to 280,000 cells/ml. The organic herds were found to have a lower incidence of clinical mastitis, teat injuries, and a lower proportion of cows with a high somatic cell count (as indicated by the UDS, Udder Disease Score) compared to conventional herds. The spectrum of udder pathogenic bacteria was similar to that found in other Swedish studies. Treatment of mastitis was found to be similar to what is practised in conventional herds. Homeopathic remedies were not widely used in the treatment of clinical mastitis.The calves in most of these organic herds suckled their dams for only a few days, which were not considered to substantially affect the udder health. The main management factor that was different from conventional herds was the feeding strategy, where organic herds used a larger share of forage. CONCLUSION: Udder health in Swedish organic herds appears to be better than in conventional herds of comparable size and production. The major difference in management between the two types of farms is the proportion of concentrates fed. The mechanisms explaining the association between intensity of feeding and udder health in dairy cows require further research.